Deliver Your News to the World

Imagine Eyes™ announces twofold growth in 2006


Imagine Eye’s announces another outstanding year of growth with an increase in revenues of over 100% in 2006 from 2005. This impressive development comes largely from increased market share for the company’s ocular wavefront analysis technologies and the full-scale commercialization of the company’s cornerstone adaptive optics product, the mirao™ 52-d Electromagnetic Deformable Mirror.

ORSAY, FRANCE – February 21, 2007 – Since the initial release of its flagship product, the irx3™ Wavefront Aberrometer, and its cornerstone adaptive optics product, the patented mirao™ 52-d Electromagnetic Deformable Mirror, Imagine Eyes’ products have continued to win the hearts and minds of customers around the world. This has shown through by an increase of 126%1 over 2005 in the company’s sales in both the clinical ophthalmology and eye health research domains. The preliminary results from the company’s customer survey conducted by Elucido Partners, an independent communications agency, show that customer satisfaction and loyalty are equally at an all-time high.

This story is best told by quoting Imagine Eyes’ customers. “The precision of the irx3 is superior to that of any other instrument we have used…” notes Professor Barbara Pierscionek2 who uses the award-winning device to study the post-surgical visual outcome of accommodating intraocular lenses (IOL) on presbyopic subjects. The professor continues by adding “…the device allows us to accurately measure human variability, without worrying about instrument error, which allows us to quickly and efficiently produce publication quality data.”

In 2006, Imagine Eyes entered into a partnership with Ziemer Ophthalmic Systems to produce the MAXWELL™ Ocular Wavefront Aberrometer, based on Imagine Eyes’ technology. MAXWELL is a totally new diagnostic device designed to meet the specific needs of refractive surgery practitioners. When asked why Imagine Eyes was such an evident technology partner choice, Frank Ziemer, President and CEO of Ziemer Group, responded “Our company is well known for providing our customers with only the best, most advanced products available. With the wide-ranging claims made by many about the precision and dynamic range of their aberrometers, the choice was clear to work with the one (Imagine Eyes) that could sustain those claims with a commercially viable product.”

Imagine Eyes’ adaptive optics products played a key role in enabling Professor Wolfgang Drexler3 and his team4,5 to produce some of the first-ever high-resolution images of a living human retina, opening new avenues into research for the early detection and treatment of retinal pathologies including macular degeneration (ARMD). Team member Dr. Enrique Fernandez4 had this to say about the company and its products “Applying adaptive optics to ophthalmology is a great step forward in the field and may help broaden our understanding of many retinal conditions that affect vision. This new insight may eventually lead to the development of new clinical tools and techniques for the early detection and treatment of these disorders.”

Imagine Eyes will continue to grow in 2007 with both a new version of its diagnostic software package and a prototype for its next-generation high-resolution retinal camera, developed in conjunction with three partner institutions6, slated for launch in 2007. For more information, please visit our website at or contact our Director of Communications, Mark Zacharria at or +33 (0)

1 Preliminary results for the fiscal year 2006 excluding subventions. Subject to change without notice.
2 Barbara Pierscionek, PhD, Professor of Optometry and Vision Science, University of Ulster, United Kingdom
3 Professor Wolfgang Drexler, PhD, Biomedical Imaging Group, Department of Optometry and Vision Sciences, Cardiff University, Wales, UK
4 Enrique Fernandez, PhD, Laboratorio de Optica, Universidad de Murcia, Centro de Investigacion en Optica y Nanotecnologia, Campus de Espindardo, Murcia, Spain
5 Laurant Vabre, PhD, Laboratoire d’Etudes Spatiales et d’Instrumentation en Astrophysique, Observatoire de Paris-Meudon, Meudon, France
6 Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts, Paris, France; Centre Hospitalier Intercommunal de Créteil, Créteil, France; Hôpital Necker Enfants Malades, Paris, France.

About Imagine Eyes

Imagine Eyes is an ophthalmic medical device company that applies its unique expertise in ocular wavefront metrology and adaptive optics to focus on professional’s needs for ophthalmic diagnostic devices that cannot effectively be addressed by other means. The company, founded in 2003 by leading scientists in the fields of adaptive optics and eye research, maintains its position as a technical leader in this domain through its innovative research and development program, wide array of patents and acclaimed product line.

©2007 Imagine Eyes. All rights reserved. Imagine Eyes, the Imagine Eyes logo, irx3, crx1 and mirao are trademarks and/or registered trademarks of Imagine Eyes. Communications managed by Elucido Partners


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.